Standard Report | Premium Report | |
---|---|---|
Current State of the Industry | ||
Market Size (industry trends) | ||
Market Forecast (5-year projection) | ||
Products/Services Breakdown | ||
Revenue per State | ||
Financial Metrics | ||
Salary & Compensation Statistics | ||
Public Company Information | ||
Key Private Companies | ||
Government Vendors | ||
Instant Download - Available immediately upon purchase | ||
Download both PDF and Excel
|
Download now: |
2025 U.S. Industry Statistics & Market Forecast - Pharmaceutical and Medicine Manufacturing
Market Size & Industry Statistics
The total U.S. industry market size for Pharmaceutical and Medicine Manufacturing:
Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders.
In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.
Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.
Statistics | 2020 2021 2022 2023 2024 | |
---|---|---|
Market Size (Total Sales/Revenue) |
Order at top of page | |
Total Firms | ||
Total Employees | ||
Average Revenue Per Firm | ||
Average Employees Per Firm | ||
Average Revenue Per Employee |
Market Forecast
Market forecasts show the long term industry outlook and future growth trends. The following extended five-year forecast projects both short-term and long-term trends.
Forecast / Industry Outlook | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
Market Forecast ($ millions) | |||||
Projected Industry Growth Rate (%) |
Industry Insights
Major trends affect the Pharmaceutical and Medicine Manufacturing industry include:- Rising demand for personalized medicine
- Shift towards biologics and specialty drugs
- Increased investment in research and development
- Regulatory changes impacting approvals and compliance
- Growth in aging populations globally
- Expansion of healthcare in emerging markets
- Technological advancements in drug development and manufacturing
- Use of artificial intelligence and machine learning
- Focus on sustainable and green manufacturing processes
- Impact of global supply chain disruptions
- Increased scrutiny on pricing and affordability of drugs
- Collaborations and partnerships in the industry
- Rise of digital health and telemedicine
- Growing importance of patient-centric healthcare services
- Enhanced focus on cybersecurity and data protection
U.S. Geographic Distribution: Revenue Statistics by State
Market Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.Income Statement (Average Financial Metrics)
Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.Industry Average | Percent of Sales (Industry Benchmark) |
|
---|---|---|
Total Revenue | Order at top of page |
|
Operating Revenue | ||
Cost of Goods Sold | ||
Gross Profit | ||
Operating Expenses | ||
Pension, profit sharing plans, stock, annuity | ||
Repairs | ||
Rent paid on business property | ||
Charitable Contributions | ||
Depletion | ||
Domestic production activities deduction | ||
Advertising | ||
Compensation of officers | ||
Salaries and wages | ||
Employee benefit programs | ||
Taxes and Licenses | ||
Bad Debts | ||
Depreciation | ||
Amortization | ||
Other Operating Expenses | ||
Total Operating Expenses | ||
Operating Income | ||
Non-Operating Income | ||
EBIT (Earnings Before Interest and Taxes) | ||
Interest Expense | ||
Earnings Before Taxes | ||
Income Tax | ||
Net Profit Net Income | ||
Financial Ratio Analysis
Financial ratio information can be used to benchmark how a Pharmaceutical and Medicine Manufacturing company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.Profitability & Valuation Ratios | Industry Average |
---|---|
Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the Pharmaceutical and Medicine Manufacturing industry is performing. | |
Profit Margin Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues. |
|
Return on Equity (ROE) Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings). |
|
Return on Assets (ROA) Return on Assets (ROA) is net income relative to total assets. The market research on Pharmaceutical and Medicine Manufacturing measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets. |
Liquidity Ratios | Industry Average |
---|---|
Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability. | |
Current Ratio Measures a firm's ability to pay its debts over the next 12 months. |
|
Quick Ratio (Acid Test) Calculates liquid assets relative to liabilities, excluding inventories. |
Efficiency Ratios - Key Performance Indicators | Industry Average |
---|---|
Measure how quickly products and services sell, and effectively collections policies are implemented. | |
Receivables Turnover Ratio If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections. |
|
Average Collection Period Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover |
|
Inventory Turnover A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort. |
|
Fixed-Asset Turnover Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue. |
Compensation & Salary Surveys for Employees
Compensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.Title | Percent of Workforce | Bottom Quartile | Average (Median) Salary | Upper Quartile |
---|---|---|---|---|
Management Occupations | 12% | Order at top of page |
||
Chief Executives | 0% | |||
General and Operations Managers | 2% | |||
Operations Specialties Managers | 5% | |||
Business and Financial Operations Occupations | 8% | |||
Business Operations Specialists | 7% | |||
Architecture and Engineering Occupations | 5% | |||
Life, Physical, and Social Science Occupations | 14% | |||
Life Scientists | 5% | |||
Office and Administrative Support Occupations | 8% | |||
Production Occupations | 34% | |||
Other Production Occupations | 29% | |||
Chemical Processing Machine Setters, Operators, and Tenders | 9% | |||
Chemical Equipment Operators and Tenders | 8% | |||
Packaging and Filling Machine Operators and Tenders | 10% | |||
Packaging and Filling Machine Operators and Tenders | 10% | |||
Transportation and Material Moving Occupations | 5% |
Pharmaceutical and Medicine Manufacturing Competitor Landscape & Key Companies [PREMIUM]
The most influential companies in the Pharmaceutical and Medicine Manufacturing industry and adjacent industries either have large market share or are developing new business models and methods that could disrupt the status quo. We look at leading and emerging companies in the Pharmaceutical and Medicine Manufacturing industry and adjacent sectors:Market Leaders: Direct Competitors Companies with the largest market share, focused in this industry |
Market leaders: Diversified Competitors Largest companies that have diversified operations in this and other industries |
Innovators: Direct Competitors Innovative, Emerging, and Disruptive Companies that may influence the future direction of the industry. |
Innovators: Diversified Competitors Innovators and Disruptors in adjacent industries that may also affect the Pharmaceutical and Medicine Manufacturing industry. |
Source:
Latest Industry News
- What’s in store for pharmaceutical sector in 2025? - The industry is set to make notable progress in cutting-edge areas such as CAR-T cell therapy, mRNA vaccines, and the development of complex molecules, which hold immense potential for driving future growth. (01/03/2025)
- CMO In Pharmaceutical Industry Market Research 2024-2028: Lower Costs, High Compliance - Why Pharma Companies Are Outsourcing To Emerging Markets - CMOs must invest in regular maintenance and upgrades to maintain their competitive edge. Labor is a significant cost for CMOs. They must hire and train skilled personnel to manage various aspects of drug manufacturing. CMOs must also ensure their workforce adheres to ethical standards and follows good manufacturing practices. (01/02/2025)
- A Closer Look at India's Leading Ayurvedic Medicine Manufacturers – WinTrust Pharmaceuticals Ltd. - WinTrust Pharmaceuticals Ltd. Top Ayurvedic Medicine Manufacturer in India has earned its reputation as a trusted name in the pharmaceutical sector. (12/31/2024)
- I Peace manufactures 100 lines of GMP iPS Cells cumulatively - Since its inception in 2015, I Peace has been working on the development of mass iPS cell manufacturing technology while engaging in the development of the iPS cell market, resulting in the cumulative manufacturing of 100 iPS cell lines today. (12/30/2024)
- Pharmaceuticals & Medicine Manufacturing Market Set To Surge At 8.9% CAGR, To Reach US$ 2,516.46 Million By 2034 | Fact.MR Report - Active Pharmaceutical Ingredient Market : Size is estimated at US$ 207.9 billion in 2024 and is forecasted to reach US$ 307.5 billion by 2034-end, advancing at a CAGR of 4% over the next ten years (2024 to 2034). (12/24/2024)
- Canadian medicine researchers looking for manufacturing partner in Bangladesh - As part of their Asian trade mission, they are in Dhaka to seek a local partner for cost-effective manufacturing and marketing of the medicine, aiming to “help millions of people fight chronic respiratory issues and viral attacks more effectively. (12/24/2024)
- Nigeria: PCN Seals Off 332 Pharmacies, Patent Medicine Shops in Jigawa - The Pharmacists Council of Nigeria (PCN) has sealed off 332 pharmacies and patent medicine shops in Jigawa ... "These include manufacturing, distribution, wholesale, retail, hospital pharmacies ... (09/30/2019)
- The fight against fake medicine requires the private sector’s help - Many other African countries are also investing in their pharmaceutical manufacturing sectors to ensure that quality-assured medicines are readily available when poor-quality medicines are detected in the market. Getting quality-assured medicines into the ... (09/29/2019)
- GSK invests $120mn in biopharmaceutical manufacturing facility - it is creating efficiencies that will significantly reduce the overall time to produce a new medicine. The newly-outfitted manufacturing space is made to be more flexible than traditional pharmaceutical manufacturing equipment. Upper Merion uses emerging ... (09/27/2019)
- Colombia looks to India for pharmaceutical raw material - To enter the Colombian market, Pharmaceutical Medicine and Equipment should be approved and registered by INVIMA to manufacture, sell, import or export. The registration of medicines and equipment in Colombia is the fastest as compared to other Latin ... (09/26/2019)
Related Reports
Can't find what you're looking for? We have over a thousand
market research reports.
Ask us and an analyst will help you find what you need.